U.S. flag

An official website of the United States government

NM_006796.2(AFG3L2):c.1997T>G (p.Met666Arg) AND Spinocerebellar ataxia 28

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
May 17, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000023377.3

Allele description

NM_006796.2(AFG3L2):c.1997T>G (p.Met666Arg)

Gene:
AFG3L2:AFG3 like matrix AAA peptidase subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18p11.21
Genomic location:
Preferred name:
NM_006796.2(AFG3L2):c.1997T>G (p.Met666Arg)
HGVS:
  • NC_000018.10:g.12337519A>C
  • NG_023361.1:g.44758T>G
  • NM_006796.2:c.1997T>G
  • NP_006787.2:p.Met666Arg
  • LRG_666t1:c.1997T>G
  • LRG_666:g.44758T>G
  • LRG_666p1:p.Met666Arg
  • NC_000018.9:g.12337518A>C
  • Q9Y4W6:p.Met666Arg
Protein change:
M666R; MET666ARG
Links:
UniProtKB: Q9Y4W6#VAR_064403; OMIM: 604581.0007; dbSNP: rs151344515
NCBI 1000 Genomes Browser:
rs151344515
Molecular consequence:
  • NM_006796.2:c.1997T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Spinocerebellar ataxia 28 (SCA28)
Identifiers:
MedGen: C1853249; Orphanet: 101109; OMIM: 610246

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000044668OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2010)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000054612GeneReviews
no assertion criteria provided
pathologic
(May 17, 2011)
not providedcuration

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providednot providednot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.

Cagnoli C, Stevanin G, Brussino A, Barberis M, Mancini C, Margolis RL, Holmes SE, Nobili M, Forlani S, Padovan S, Pappi P, Zaros C, Leber I, Ribai P, Pugliese L, Assalto C, Brice A, Migone N, Dürr A, Brusco A.

Hum Mutat. 2010 Oct;31(10):1117-24. doi: 10.1002/humu.21342.

PubMed [citation]
PMID:
20725928

Details of each submission

From OMIM, SCV000044668.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 affected members a family with autosomal dominant SCA28 (610246), Cagnoli et al. (2010) identified a heterozygous 1997T-G transversion in exon 16 of the AFG3L2 gene, resulting in a met666-to-arg (M666R) substitution in a highly conserved residue in the C-terminal proteolytic peptidase-M41 domain. Met666 is located on the surface of the AFG3L2 complex, and the mutation was predicted to decrease the electrostatic potential difference between the inner mitochondrial membrane side and the matrix side of the hexameric complex, as well as decrease the central pore dipole. These findings suggested a destabilizing effect. The mutation was not identified in 380 French or Italian control chromosomes.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000054612.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

Converted during submission to Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot providednot providednot providedAssert pathogenicitynot providednot providednot providednot provided

Last Updated: Dec 9, 2017